Metropolis Healthcare Ltd

#DiagnosticOncology has come a long way courtesy of technological advancement, precision oncology, and companion diagnostics culminating into optimal patient care. This #worldcancerday2023 , Dr Kirti Chadha, Chief Scientific Officer, Metropolis Labs joins other leading Oncology specialists to share her views with The Times of India on the advancements in diagnosis and treatment of cancer. #MolecularOncology #MetropolisScientificExpert #Cancer #Diagnosis #Oncomet #Research #Innovation #ScientificExcellence #Healthcare #MetropolisLab #DiagnosticOncology #worldcancerday2023 #MolecularOncology #MetropolisScientificExpert #Cancer #Diagnosis #Oncomet #Research #Innovation #ScientificExcellence #Healthcare #MetropolisLab

Check out this industry trend story reported by Sohini Das of Business Standard, in which Dr. Nilesh Shah (President and Chief of Science and Innovation, Metropolis Labs) shares his views on the role & share of Artificial Intelligence-based platforms in diagnosis. For online version, click here: https://lnkd.in/dNPJZTSt#healthcare #diagnosis #metropolisscientificexpert #artificialintelligence #metropolislabs #science #research #innovation #diagnostics #leadership #healthcare #diagnosis #metropolisscientificexpert #artificialintelligence #metropolislabs #science #research #innovation #diagnostics #leadership

At #Metropolis, we have been not only working on bringing various types of tests for #cancerdiagnosis , but also have been making every effort to raise awareness about #cancer and its different types, their symptoms, causes, diagnosis, and treatment among the masses through different platforms. Here’s an explanatory video interview on Thehealthsite.com of our #MetropolisScientificExpert Dr Chakshu Bansal (DGM - Lab Operations, Consultant Pathologist, Delhi Reference Lab) speaking on #Leukemia (#bloodcancer ) which is a cancer of the blood cells within the bone marrow. #MetropolisHealthcare #Metropolislab #Oncopathology #Healthcare #Research #Innovation #BloodCancer #CancerDiagnosishttps://www.thehealthsite.com/videos/leukemia-know-the-symptoms-of-leukemia-and-its-treatment-watch-video-889852/ #Metropolis #cancerdiagnosis #cancer #MetropolisScientificExpert #Leukemia #bloodcancer #MetropolisHealthcare #Metropolislab #Oncopathology #Healthcare #Research #Innovation #BloodCancer #CancerDiagnosis

#Genetictesting plays an integral part in diagnosing and treating lung cancer. Genetic testing looks for mutations which help develop tailored treatment plans. Using Genetic testing, one can identify changes in lung cells that may trigger and contribute to cancer growth – “Biomarkers”. Identifying the biomarkers helps Oncologist arrive at the best approach to treatment. These targeted therapies are less invasive than traditional cancer treatments because they do not destroy healthy cells – they stop the cancer cells from growing and reproducing.” – says #MetropolisScientificexpert Dr Kirti Chadha, (Chief Scientific Officer, Metropolis Healthcare) in her interview to #Onlymyhealth. Find out more in this article, as she elaborates on the importance of Genetic testing in early detection, and treatment of #LungCancer. Want to know more about the Genetic testing available at Metropolis, write to our experts on medconnect@metropolisindia.com #MetropolisLabs #Healthcare #Oncology #Cancer #LungCancer #Diagnosis #Leadingdiagnosticplayer #Lungcancertesting #BRCA #NextGenBRCA #MolecularOncology #Research #Innovation #accesstohealthcare #Affordablediagnosishttps://www.onlymyhealth.com/genetic-testing-lung-cancer-importance-1661016165 #Genetictesting #MetropolisScientificexpert #Onlymyhealth #LungCancer #MetropolisLabs #Healthcare #Oncology #Cancer #Diagnosis #Leadingdiagnosticplayer #Lungcancertesting #BRCA #NextGenBRCA #MolecularOncology #Research #Innovation #accesstohealthcare #Affordablediagnosis

We are pleased to inform that Metropolis Labs Chief Scientific Officer Dr Kirti Chadha will be joining as a Panelist alongside other key leaders in healthcare tomorrow at the event titled ‘Technovation: The Future of Women’s Healthcare’. Hosted by Confederation of Indian Industry''s Indian Women Network, Dr. Kirti will be speaking on ‘Women’s Wellness: Services in Healthcare” at the 4th edition of She Matters. #healthcare #Womenshealth #Metropolislabs #Research #Innovation #Womenswellness #Leadership #diversityandinclusion #diagnostics #Shematters #womenshealthmatters #ESG #Sustainability #MetropolisImpact #technovation #digitization #healthcare #Womenshealth #Metropolislabs #Research #Innovation #Womenswellness #Leadership #diversityandinclusion #diagnostics #Shematters #womenshealthmatters #ESG #Sustainability #MetropolisImpact #technovation #digitization

Metropolis Labs in Ghana is proud to announce that it has won the ‘Overall Best Pathology Laboratory Centre of the Year’ Award at the Ghana Medical Laboratories Excellence Awards (GMLEA). GMLEA is an initiative of HeFRA (Health Facilities Regulatory Agency). #HeFRA, which is part of the Government of Ghana, is engaged in the licensing and monitoring of private and public health facilities in Ghana. #BestDiagnosticLaboratory #ResearchExcellence #leadingdiagnosticserviceprovider #Healthcare #commitmenttopatients #HeFRA #BestDiagnosticLaboratory #ResearchExcellence #leadingdiagnosticserviceprovider #Healthcare #commitmenttopatients

#BreastCancer and #OvarianCancer are the most common forms of cancer in women and constitute a major cause of cancer related mortality in women. Around 10-15% of breast cancers are attributed to mutations or alterations in #BReastCAncerGene (BRCA ½) genes, causing 40-50% of #hereditarybreastcancers. Experts suggest that the early risk detection of breast cancer through genetic testing can help in better management. In this article covered in #Onlymyhealth, Dr. Monisha Banerjee, Senior Consultant, Molecular Genomics and Genetic Counselling, Metropolis Healthcare Limited speaks on the significance of #Genetictesting, Pre & Post Counselling for the early detection of Breast Cancer risk. Want to know more about the Breast Cancer Gene Test available at Metropolis, write to our experts on medconnect@metropolisindia.com #Research #BRCA #Healthcare #Cancerscreening #HBOC #genomics #molecularoncology #metropolisinnovationcell #innovation #oncomethttps://www.onlymyhealth.com/genetic-counseling-breast-cancer-risk-1656941880 #BreastCancer #OvarianCancer #BReastCAncerGene #hereditarybreastcancers #Onlymyhealth #Genetictesting #Research #BRCA #Healthcare #Cancerscreening #HBOC #genomics #molecularoncology #metropolisinnovationcell #innovation #oncomet

Symptoms of allergy start immediately or within 2-3 hours of exposure, while intolerance symptoms may not be immediate. In addition, the severity of symptoms may be far lesser when compared to allergy which can be life-threatening at times. In a study conducted at Metropolis Labs, it was found that around 600+ individuals have intolerance for some or the other food. Check out this insightful piece authored by Dr Alap Christy, Associate VP and Scientific Business Head – Clinical Chemistry at Metropolis Labs, in which he explains about the most common food intolerances, their screening method and the way to overcome such food intolerances. Click on the link to read the online version of the article:https://lnkd.in/gxmw-YHZ#foodintolerances #microarraytechnique #healthcare #research #foodintolerancetesting #foodintolerances #microarraytechnique #healthcare #research #foodintolerancetesting

We are pleased to invite you for a session by our expert Dr. Kirti Chadha, Sr Vice President - Operations & Medical Affairs, Sr Consultant Onco pathologist, MD, PDCC (Oncopath & Oncohemat), Metropolis Healthcare Limited on the topic “Issues in Digital and Computational Pathology” at International Course in Computational Pathology 2020 at Tata Medical Center, Kolkata, Thursday on 16 January 2020. #Healthcare #Oncology #ResearchandDevelopment #DigitalPathology #ComputationalPathology #Kolkata #Biotechnology #Test #Cancer #Diagnosis